E Henderson
About
In The Last Decade
E Henderson
7 papers receiving 147 citations
Peers
Comparison fields: 5 of 54
- Public Health, Environmental and Occupational Health 87
- Hematology 70
- Oncology 42
- Education 25
- Genetics 23
Countries citing papers authored by E Henderson
This map shows the geographic impact of E Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Henderson more than expected).
Fields of papers citing papers by E Henderson
This network shows the impact of papers produced by E Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Henderson. The network helps show where E Henderson may publish in the future.
Co-authorship network of co-authors of E Henderson
This figure shows the co-authorship network connecting the top 25 collaborators of E Henderson. A scholar is included among the top collaborators of E Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Henderson. E Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A study comparing LETZ and CO2 laser treatment for cervical intra epithelial neoplasia with and without associated human papilloma virus. | 7 |
| 2 | Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study. | 6 |
| 3 | 94 | |
| 4 | 32 | |
| 5 | Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer. | 12 |
| 6 | HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia. | 3 |
| 7 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.